loading
전일 마감가:
$0.2805
열려 있는:
$0.3
하루 거래량:
147.24K
Relative Volume:
0.40
시가총액:
$10.93M
수익:
-
순이익/손실:
$-23.36M
주가수익비율:
-0.3845
EPS:
-0.7368
순현금흐름:
-
1주 성능:
-11.47%
1개월 성능:
-30.97%
6개월 성능:
-79.91%
1년 성능:
-84.35%
1일 변동 폭
Value
$0.28
$0.30
1주일 범위
Value
$0.2797
$0.32
52주 변동 폭
Value
$0.2797
$3.89

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Name
명칭
Calidi Biotherapeutics Inc
Name
전화
(858) 794-9600
Name
주소
4475 Executive Drive, Suite 200, San Diego
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CLDI's Discussions on Twitter

CLDI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CLDI
Calidi Biotherapeutics Inc
0.28 10.93M 0 -23.36M 0 -0.7368
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
440.33 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
510.76 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
310.25 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
539.40 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.53 28.51B 3.81B -644.79M -669.77M -6.24

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-11-22 개시 H.C. Wainwright Buy
2023-10-09 개시 Robert W. Baird Outperform

Calidi Biotherapeutics Inc 주식(CLDI)의 최신 뉴스

pulisher
Jun 13, 2025

Millennium Management LLC Increases Stake in Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

Calidi Biotherapeutics Appoints Biotech Veteran Eric Poma, PhD, as CEO to Lead Next Growth Phase - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Takes Position in Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

Jun 10, 2025
pulisher
Jun 06, 2025

Calidi Biotherapeutics Unveils Promising Data on CLD-401 at ASCO 2025 - citybuzz -

Jun 06, 2025
pulisher
Jun 02, 2025

Calidi Biotherapeutics Presents systemic oncolytic platform - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Calidi Biotherapeutics (CLDI) Showcases Innovative CLD-401 Thera - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Revolutionary Cancer Treatment Breakthrough: Calidi's New Systemic Delivery Platform Wows ASCO Conference - Stock Titan

Jun 02, 2025
pulisher
Jun 01, 2025

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock - The Globe and Mail

Jun 01, 2025
pulisher
May 30, 2025

Calidi Biotherapeutics (NYSE:CLDI) Shares Down 5.3% – Time to Sell? - Defense World

May 30, 2025
pulisher
May 16, 2025

Calidi Biotherapeutics, Inc. (CLDI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Yahoo Finance

May 16, 2025
pulisher
May 14, 2025

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results And Recent Operational Highlights - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Calidi Biotherapeutics Secures FDA Green Light for Cancer Trial as New CEO Reveals Q1 Financials - Stock Titan

May 14, 2025
pulisher
May 07, 2025

Candel Therapeutics (NASDAQ:CADL) vs. Calidi Biotherapeutics (NYSE:CLDI) Critical Review - Defense World

May 07, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Buys 120,406 Shares of Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

May 04, 2025
pulisher
May 02, 2025

CLDICalidi Biotherapeutics Inc Latest Stock News & Market Updates - Stock Titan

May 02, 2025
pulisher
May 01, 2025

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5 - The Globe and Mail

May 01, 2025
pulisher
Apr 29, 2025

Calidi Biotherapeutics (NYSE:CLDI) Stock Price Down 0.3% – Time to Sell? - Defense World

Apr 29, 2025
pulisher
Apr 29, 2025

Investor’s Delight: Calidi Biotherapeutics Inc (CLDI) Closes Weak at 0.65, Down -6.53 - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Calidi (CLDI) Advances Cancer Treatment with IL15 Superagonist a - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

Calidi Biotherapeutics Announces IL15 Superagonist as First - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Revolutionary Cancer Treatment Platform Shows Complete Tumor Elimination: First Systemic Delivery Success - Stock Titan

Apr 28, 2025
pulisher
Apr 25, 2025

Calidi Biotherapeutics (CLDI) Awards Stock Option to New CEO Eri - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

Calidi Bio's Strategic Move: New CEO Secures 726K Share Options with 4-Year Performance Lock - Stock Titan

Apr 25, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics appoints new CEO By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Zealand names former Lilly exec Singh as CSO - BioCentury

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics appoints new CEO - Investing.com

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi (CLDI) Appoints New CEO as Eric Poma Assumes Leadership | - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics Appoints New CEO Eric Poma - TipRanks

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics Announces Chief Executive Officer Transition And Appointment Of Eric Poma, Ph.D. As CEO And Director - TradingView

Apr 23, 2025
pulisher
Apr 23, 2025

Calidi Biotherapeutics Announces Chief Executive Officer - GlobeNewswire

Apr 23, 2025
pulisher
Apr 23, 2025

New Calidi Bio CEO Brings $400M Funding Success Record: Strategic Shift for Cancer Treatment Pioneer - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor - The Globe and Mail

Apr 22, 2025
pulisher
Apr 22, 2025

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24 - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24 - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

Cancer Breakthrough Alert: Top Oncologist Reveals New FDA-Cleared Stem Cell Therapy Development - Stock Titan

Apr 22, 2025
pulisher
Apr 17, 2025

Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors - The Manila Times

Apr 17, 2025
pulisher
Apr 17, 2025

FDA Green Lights Revolutionary Cancer Treatment: Stem Cells Combined With Virus to Fight Multiple Tumors - Stock Titan

Apr 17, 2025
pulisher
Apr 10, 2025

Calidi Biotherapeutics Announces Appointment of Guy Travis - GlobeNewswire

Apr 10, 2025
pulisher
Apr 10, 2025

Cancer Drug Developer Calidi Bio Strengthens Leadership: Renowned Oncologist Takes CMO Role - Stock Titan

Apr 10, 2025
pulisher
Apr 10, 2025

Calidi Biotherapeutics Appoints New Chief Medical Officer - TipRanks

Apr 10, 2025
pulisher
Apr 08, 2025

CLDI stock touches 52-week low at $0.42 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

CLDI stock touches 52-week low at $0.42 amid market challenges - Investing.com India

Apr 08, 2025
pulisher
Apr 08, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 05, 2025

ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Apr 05, 2025
pulisher
Apr 05, 2025

HighTower Advisors LLC Makes New Investment in Calidi Biotherapeutics, Inc. (NYSE:CLDI) - Defense World

Apr 05, 2025
pulisher
Apr 01, 2025

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights - The Manila Times

Apr 01, 2025
pulisher
Mar 31, 2025

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

CLDI stock plunges to 52-week low, hitting $0.57 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Calidi Bio Raises Fresh $3.9M Capital to Advance Clinical Programs - Stock Titan

Mar 31, 2025

Calidi Biotherapeutics Inc (CLDI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.89
price down icon 0.66%
$35.12
price up icon 1.05%
$20.60
price up icon 1.48%
$102.01
price down icon 1.01%
$105.16
price down icon 1.24%
biotechnology ONC
$258.31
price up icon 6.02%
자본화:     |  볼륨(24시간):